Biocon Biologics Ltd

IMT News Desk February 13, 2024
514

Biocon Biologics partners with Sandoz Australia

Sandoz will distribute the Biocon Biologics’ brands, OGIVRI (bTrastuzumab) and ABEVMY (bBevacizumab), and facilitate sustained access to these medications Biocon…
Read More »
IMT News Desk December 7, 2022
536

Shreehas Tambe appointed as MD and CEO of Biocon Biologics

Tambe will lead the company in realising its goal of being a global biosimilar leader Biocon Biologics Ltd (BBL), a…
Read More »